Alok Shetty

6PUBLICATIONS
78CO-AUTHORS
Aerospace structuresHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical bacteriologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 20, 2026
Validation and Refinement of the European LeukemiaNet 2022 Genetic Risk Stratification of AML.

Gojiri Mawalankar, Aarti Achrekar, Seema Biswas

|Jan 23, 2026
Risk of Hepatitis B Reactivation Among ALL Patients With Occult Hepatitis B Infection.

Hasmukh Jain, Neha Sharma, Devanshee Shah

|Mar 07, 2025
Real-World Analysis Evaluating Treatment Eligibility and Outcomes in Patients With AML Receiving Intensive Chemotherapy: Insights From an Underrepresented Population.

Hasmukh Jain, Thomas Eipe, Alok Shetty

|Oct 31, 2024
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium.

Jessy Xinyi Han, Min Jung Koh, Leora Boussi

|Feb 01, 2024
Clinical Utility of Stepwise Bronchoalveolar Lavage Fluid Analysis in Diagnosing and Managing Lung Infiltrates in Leukemia/Lymphoma Patients With Febrile Neutropenia.

Jayashree Thorat, Surabhi Bhat, Manju Sengar

|Jan 27, 2023
Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation.

Vijay Maruti Patil, Vanita Noronha, Nandini Menon

Pageof 1

Frequent Collaborators

5 joint publications

Hasmukh Jain

5 joint publications

Manju Sengar

4 joint publications

Lingaraj Nayak

4 joint publications

Bhausaheb Pandurang Bagal